Clinical trials
Active, not recruiting Phase 3 Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agios Pharmaceuticals, Inc. | 2 |
| Eli Lilly and Company | 2 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Pfizer | 1 |
| Rezolute | 1 |
| iECURE, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 8 |
| Glucose Metabolism Disorders | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Endocrine System Diseases | 3 |
| Anemia | 2 |
| Diabetes Mellitus | 2 |
| Hematologic Diseases | 2 |
| Amino Acid Metabolism, Inborn Errors | 1 |
| Body Weight | 1 |
| Brain Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.